Science, Tech & Innovation News

Earth Day 2025, under the theme of “Our Power, Our Planet,” invites the world to support renewable energy for a more sustainable future. The theme resonates with BLUETTI’s mission to empower a greener planet with clean energy solutions.

Using a U-lock can be a hassle, as you have to pull it out of your bag, take it apart, then run its shackle through the bike's frame. The bike-mounted V-160 offers a simpler approach, in that you just push it head-first into whatever's at hand.

Valvular heart disease (VHD) is a potentially fatal condition, yet it's hard to diagnose with a regular stethoscope. A possibly life-saving new stethoscope is claimed to be much better at the job, plus it can be used by just about anyone.

Researchers have developed DolphinGemma, the first LLM for understanding dolphin language. It could help us translate what these incredible creatures are saying, potentially much faster than we ever could with manual approaches used over decades.

Consuming cannabis can certainly be a way to deal with some health conditions like chronic pain or insomnia. But when a user goes too far and winds up in the hospital, the negative consequences can reach far into the future, says a new study.

There appears to be a race on to launch the first 13.3-inch color ePaper monitor. Dasung currently has an Indiegogo waiting in the wings, but it's looking like Bigme will be first to the line with pre-order status for its B13 device.

TL;DR: Consolidate your AI bot tools in one place with a 1min.AI lifetime subscription for under $80.

Not everyone with ADHD responds to stimulants like Ritalin, which increase dopamine levels. New research suggests the drug’s effectiveness is less about the dopamine it produces and more about the number and type of brain receptors that respond to it.

The Trail Mod trailer is one in a new wave of ultra-modular trailers that build up from bare bones to fully capable adventure wagons. It starts as a rugged utility flatbed and builds up into a capable toy-hauling micro-camper.

A three-year study has found robust evidence that one vaccine for respiratory syncytial virus offers older adults long-term protection, even if efficacy wanes. Despite this, just one dose cut serious illness by nearly two thirds across three seasons.